COMPARATIVE EFFECTIVENESS AND SAFETY OF EMPAGLIFLOZIN: AN INTERIM ANALYSIS FROM THE EMPAGLIFLOZIN COMPARATIVE EFFECTIVENESS AND SAFETY (EMPRISE) STUDY
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)31291-4
Abstract: EMPRISE is a study program on the effectiveness, safety and healthcare utilization of empagliflozin (EMPA), a SGLT2 inhibitor (SGLT2i), in routine care across a spectrum of cardiovascular (CV) baseline risk using real-world data from 2… read more here.
Keywords: empagliflozin; emprise study; effectiveness; effectiveness safety ... See more keywords